Patent · US Active

S1P3 receptor antagonist

US8546452B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

TOA EIYO LTD · SS

Inventors

Shin-ya Ohnuma · Chuo, JP
Takeshi Hasegawa · Tokyo, JP
Tomoyuki Sada · Saitama, JP

Key dates

Filing date	Oct 11, 2006
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Nov 5, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to arylamidrazone derivatives having an antagonistic action against S1P3 receptors represented by the following formula (1) or a pharmaceutically acceptable salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.